Kuvan®
Kuvan® (sapropterin dihydrochloride) is indicated for the treatment of hyperphenylalaninemia (HPA) in adults and children
of 4 years of age and over with phenylketonuria (PKU) who have been shown to be responsive to such treatment.
Kuvan is also indicated for the treatment of hyperphenylalaninaemia (HPA) in adult and pediatric patients with tetrahydrobiopterin
(BH4) deficiency who have been shown to be responsive to such treatment.
Active management of dietary phenylalanine and overall protein intake while taking Kuvan is required to ensure adequate control
of blood phenylalanine levels and nutritional balance.
| Disclaimer |
|
The information in this section is intended for Healthcare Professionals only. US residents should consult the EMD Serono, Inc. for information on products approved for sales in the United States of America. |